[Clinical use and effect of Ro 5-4023 (clonazepam) in different forms of epileptic seizures].
D000284:Administration, Oral; D000293:Adolescent; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001570:Benzodiazepinones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002722:Chlorobenzenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004827:Epilepsy / Q000188:drug therapy*; D005221:Fatigue / Q000139:chemically induced; D006801:Humans; D007275:Injections, Intravenous; D009567:Nitrazepam / Q000627:therapeutic use; D009574:Nitro Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D013997:Time Factors
D000927:Anticonvulsants; D001570:Benzodiazepinones; D002722:Chlorobenzenes; D009574:Nitro Compounds; D009567:Nitrazepam
Zusammenfassender Erfahrungsbericht über die klinische Anwendung und Wirksamkeit von Ro 5-4023 (Clonazepam) auf verschiedene Formen epileptischer Anfälle.